Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics ...
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Medpage Today on MSN
Investigational Combination Shows Promise in Chronic Hepatitis D
WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
PRIMETIMER on MSN
Complete cast breakdown of Pluribus season 1: Who plays who & where you’ve heard or seen them before
Pluribus season 1 premiered on Apple TV on November 7, 2025. Read on to discover who stars in the show.
The devastating retrovirus HTLV-1 has eluded scientists for decades. Overcoming chronic funding and other challenges, ...
In a world gripped by the challenges of viral outbreaks, the global anti-viral therapies market stands as a beacon of hope. With a valuation of $38,316.5 million in 2018, the mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback